ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $243,762 | +10.3% | 11,280 | -1.2% | 0.00% | – |
| Q3 2022 | $221,000 | -1.8% | 11,416 | +0.7% | 0.00% | – |
| Q2 2022 | $225,000 | -30.6% | 11,335 | +4.5% | 0.00% | – |
| Q1 2022 | $324,000 | +37.9% | 10,846 | +7.3% | 0.00% | – |
| Q4 2021 | $235,000 | -19.0% | 10,112 | +9.0% | 0.00% | – |
| Q3 2021 | $290,000 | -10.5% | 9,279 | +0.9% | 0.00% | – |
| Q2 2021 | $324,000 | -23.6% | 9,200 | -23.5% | 0.00% | – |
| Q1 2021 | $424,000 | -40.4% | 12,028 | -36.5% | 0.00% | – |
| Q4 2020 | $711,000 | +214.6% | 18,929 | +172.8% | 0.00% | – |
| Q1 2018 | $226,000 | – | 6,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |